Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Mannie

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 19, 2020
Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination <i>in vivo</i> and Promote Dominance of FOXP3<sup>+</sup> Tregs <i>in vitro</i>Kayla B DeOca, Cody D Moorman, Brandon L Garcia, et al.
Cellular Immunology|January 15, 2023
Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25<sup>high</sup> regulatory and memory T cellsRebecca A Nickle, Kayla B DeOca, Brandon L Garcia, et al.
Viruses|May 28, 2025
A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral ActivityHoda H Jabbour, Alexander G Bastian, Kayla B DeOca, et al.
Journal of Neuroinflammation|June 12, 2020
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4<sup>+</sup> CD25<sup>+</sup> FOXP3<sup>+</sup> Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)Cody D Moorman, Alexander G Bastian, Kayla B DeOca, et al.
Frontiers in Immunology|August 31, 2012
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosisMark D Mannie, J Lori Blanchfield, S M Touhidul Islam, et al.
Immunology|April 4, 2021
Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseasesS M Touhidul Islam, Jeseong Won, Mushfiquddin Khan, et al.
Frontiers in Immunology|January 10, 2018
Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25<sup>high</sup> FOXP3<sup>+</sup> Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive ImmunotherapyDaniel S Wilkinson, Debjani Ghosh, Rebecca A Nickle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2014
GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentationS M Touhidul Islam, Alan D Curtis, Najla Taslim, et al.
Cellular Immunology|November 16, 2004
MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signalsMark D Mannie, John G Dawkins, Mindi R Walker, et al.
Frontiers in Immunology|January 29, 2019
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4<sup>+</sup> CD25<sup>high</sup> FOXP3<sup>+</sup> Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor RecognitionCody D Moorman, Alan D Curtis, Alexander G Bastian, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 19, 2020
Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination <i>in vivo</i> and Promote Dominance of FOXP3<sup>+</sup> Tregs <i>in vitro</i>Kayla B DeOca, Cody D Moorman, Brandon L Garcia, et al.
Cellular Immunology|January 15, 2023
Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25<sup>high</sup> regulatory and memory T cellsRebecca A Nickle, Kayla B DeOca, Brandon L Garcia, et al.
Viruses|May 28, 2025
A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral ActivityHoda H Jabbour, Alexander G Bastian, Kayla B DeOca, et al.
Journal of Neuroinflammation|June 12, 2020
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4<sup>+</sup> CD25<sup>+</sup> FOXP3<sup>+</sup> Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)Cody D Moorman, Alexander G Bastian, Kayla B DeOca, et al.
Frontiers in Immunology|August 31, 2012
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosisMark D Mannie, J Lori Blanchfield, S M Touhidul Islam, et al.
Immunology|April 4, 2021
Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseasesS M Touhidul Islam, Jeseong Won, Mushfiquddin Khan, et al.
Frontiers in Immunology|January 10, 2018
Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25<sup>high</sup> FOXP3<sup>+</sup> Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive ImmunotherapyDaniel S Wilkinson, Debjani Ghosh, Rebecca A Nickle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2014
GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentationS M Touhidul Islam, Alan D Curtis, Najla Taslim, et al.
Cellular Immunology|November 16, 2004
MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signalsMark D Mannie, John G Dawkins, Mindi R Walker, et al.
Frontiers in Immunology|January 29, 2019
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4<sup>+</sup> CD25<sup>high</sup> FOXP3<sup>+</sup> Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor RecognitionCody D Moorman, Alan D Curtis, Alexander G Bastian, et al.
Pageof 3